Raheleh Alimoradzadeh - Firoozabadi Clinical Research Development Unit (FACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran
Hosna Ranjbar - Iran University of Medical Sciences, Tehran, Iran
Mohammad Amin Abbasi - Firoozabadi Clinical Research Development Unit (FACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran
Fatemeh Montazer - Firoozabadi Clinical Research Development Unit (FACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran

The present study was a cross-sectional investigation carried out on elderly patients under chronic hemodialysis who referred to Firoozabadi Hospital during ۲۰۱۹- ۲۰۲۰. The study population was ۸۰ patients ≥ ۶۰ years. The patients’ cognitive status was determined using MMSE and MOCA tools. The mean age of the candidate patients was ۷۱.۷۱ ± ۶.۲۸ years old. Cognitive function was assessed by MMSE and MoCA tests and the mean score of the MMSE test was ۲۰.۰۵ ± ۳.۵۰ with the highest score being ۲۶ and the lowest score being ۱۲. Based on the results, these patients were divided into three groups with normal cognitive ­function, mild cognitive impairment, and severe cognitive impairment. According to the results of the MMSE test, ۱۹ patients (۲۳.۷۵%) had a normal cognitive function and ۴۵ patients (۵۶.۲۵%) had impairment. In other words, the older patients, the lower level of education, the longer duration of hemodialysis, and the patients with a history of diabetes were more susceptible to cognitive impairment. Subsequently, there was a positive correlation between the levels of BUN, creatinine, uric acid, and PTH, which means that the higher level of these variables in patients was related to the higher risk of cognitive impairment. The findings of the present investigation revealed that the cognitive function and the studied variables including age, level of education, history of diabetes, hemodialysis duration, BUN, Creatinine, Uric Acid, PTH, Sodium, and Kt/V had a significant difference in patients undergoing hemodialysis. 

Elderly, Chronic hemodialysis, Cognitive Impairment, Diabetes